Magnetofection - A highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo

Molecular Therapy

Volumn 7, Issue 5, 2003, Pages 700-710

  Krötz, Florian ^a   de Wit, Cor ^a   Sohn, Hae Young ^a   Zahler, Stefan ^a   Gloe, Torsten ^a   Pohl, Ulrich ^a   Plank, Christian ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antisense oligonucleotides; Endothelial NAD(P)H oxidase; Magnetic field guided nucleic acid delivery; Magnetofection; Superoxide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CONNEXIN 37; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHATASE; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMORAL ARTERY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; MOUSE; MUSCLE BLOOD VESSEL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

ANIMALIA;

EID: 0038190867     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00065-0     Document Type: Article

References (40)

1. Cai, H., and Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 87: 840-844.
2. Wolin, M. S. (2000). Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 20: 1430-1442.
3. Miller, F. J. Jr., Gutterman, D. D., Rios, C. D., Heistad, D. D., and Davidson, B. L. (1998). Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82: 1298-1305.
4. Sorescu, D., et al. (2002). Superoxide production and expression of NOX family proteins in human atherosclerosis. Circulation 105: 1429-1435.
5. West, N., Guzik, T., Black, E., and Channon, K. (2001). Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: Role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 21: 189-194.
6. - and systolic blood pressure in mice. Circ. Res. 89: 408-414.
7. Wassmann, S., et al. (2001). HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37: 1450-1457.
8. Guzik, T. J., et al. (2002). Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662.
9. Wassmann, S., et al. (2002). Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 22: 300-305.
10. Griendling, K. K., Sorescu, D., and Ushio-Fukai, M. (2000). NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ. Res. 86: 494-501.
11. Bayraktutan, U., Blayney, L., and Shah, A. M. (2000). Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20: 1903-1911.
12. Knoller, S., Shpungin, S., and Pick, E. (1991). The membrane-associated component of the amphiphile-activated, cytosol-dependent superoxide-forming NADPH oxidase of macrophages is identical to cytochrome b559. J. Biol. Chem. 266: 2795-2804.
13. Krötz, F., et al. (2002). NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recuritment. Blood 100: 917-924.
14. Gorlach, A., et al. (2000). Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 14: 1518-1528.
15. Heinloth, A., Heermeier, K., Raff, U., Wanner, C., and Galle, J. (2000). Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 11: 1819-1825.
16. Edgell, C. J., Curiel, D. T., Hu, P. C., and Marr, H. S. (1998). Efficient gene transfer to human endothelial cells using DNA complexed to adenovirus particles. Biotechniques 25: 264-268, 270-272
17. Tanner, F. C., Carr, D. P., Nabel, G. J., and Nabel, E. G. (1997). Transfection of human endothelial cells. Cardiovasc. Res. 35: 522-528.
18. Teifel, M., Heine, L. T., Milbredt, S., and Friedl, P. (1997). Optimization of transfection of human endothelial cells. Endothelium 5: 21-35.
19. Aramaki, Y., Takano, S., and Tsuchiya, S. (2001). Cationic liposomes induce macrophage apoptosis through mitochondrial pathway. Arch. Biochem. Biophys. 392: 245-250.
20. Scherer, F., et al. (2002). Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9: 102-109.
21. Finsinger, D., Remy, J. S., Erbacher, P., Koch, C., and Plank, C. (2000). Protective copolymers for nonviral gene vectors: Synthesis, vector characterization and application in gene delivery. Gene Ther. 7: 1183-1192.
22. Sohn, H. Y., Keller, M., Gloe, T., Morawietz, H., Rueckschloss, U., and Pohl, U. (2000). The small G-protein Rac mediates depolarization induced superoxide formation in human endothelial cells. J. Biol. Chem. 275: 18745-18750.
23. Sohn, H. Y., Gloe, T., Keller, M., Schoenafinger, K., and Pohl, U. (1999). Sensitive superoxide detection in vascular cells by the new chemiluminescence dye L-012. J. Vasc. Res. 36: 456-464.
24. De Wit, C., von Bismarck, P., and Pohl, U. (1993). Mediator role of prostaglandins in acetylcholine-induced vasodilation and control of resting vascular diameter in the hamster cremaster microcirculation in vivo. J. Vasc. Res. 30: 272-278.
25. Armeanu, S., et al. (2000). Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol. Ther. 1: 366-375.
26. Hughes, J., et al. (2000). In vitro transport and delivery of antisense oligonucleotides. Methods Enzymol. 313: 342-358.
27. Babior, B. M. (1999). NADPH oxidase: An update. Blood 93: 1464-1476.
28. Garcia-Chaumont, C., Seksek, O., Grzybowska, J., Borowski, E., and Bolard, J. (2000). Delivery systems for antisense oligonucleotides. Pharmacol. Ther. 87: 255-277.
29. Iversen, P. L., Zhu, S., Meyer, A., and Zon, G. (1992). Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev. 2: 211-222.
30. Marcusson, E. G., Bhat, B., Manoharan, M., Bennett, C. F., and Dean, N. M. (1998). Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res. 26: 2016-2023.
31. Chuck, A. S., Clarke, M. F., and Palsson, B. O. (1996). Retroviral infection is limited by Brownian motion. Hum. Gene Ther. 7: 1527-1534.
32. Mollnau, H., Wendt, M., Szocs, K., Lassegue, B., Schulz, E., and Oelze, M. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90: E58-E165.
33. Fukui, T., et al. (1997). p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80: 45-51.
34. Gardemann, A., Mages, P., Katz, N., Tillmanns, H., and Haberbosch, W. (1999). The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145: 315-323.
35. Cahilly, C., Ballantyne, C. M., Lim, D. S., Gotta, A., and Marian, A. J. (2000). A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ. Res. 86: 391-395.
36. Taniyama, Y., et al. (2002). Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105: 1233-1239.
37. Morishita, R., Aoki, M., Kaneda, Y., and Ogihara, T. (2001). Gene therapy in vascular medicine: Recent advances and future perspectives. Pharmacol. Ther. 91: 105-114.
38. Landau, C., Lange, R. A., and Hillis, L. D. (1994). Percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 330: 981-993.
39. Santiago, F. S., and Khachigian, L. M. (2001). Nucleic acid based strategies as potential therapeutic tools: Mechanistic considerations and implications to restenosis. J. Mol. Med. 79: 695-706.
40. Kipshidze, N. N., Kim, H. S., Iversen, P., Yazdi, H. A., Bhargava, B., and New, G. (2002). Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. J. Am. Coll. Cardiol. 39: 1686-1691.